First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates.
J Midlife Health
; 5(1): 29-33, 2014 Jan.
Article
em En
| MEDLINE
| ID: mdl-24672203
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Clinical_trials
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article